Bank of Montreal
RVLP

Bank of Montreal’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bank of Montreal’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-374
Closed -$1K – 5200
2021
Q1 		$1K Sell
374
-1,606
-81% -$6.61K ﹤0.01% 5020
2020
Q4 		$9K Buy
1,980
+1,379
+229% +$7.95K ﹤0.01% 4690
2020
Q3 		$3K Sell
601
-353
-37% -$2.03K ﹤0.01% 4606
2020
Q2 		$7K Buy
954
+516
+118% +$2.52K ﹤0.01% 4351
2020
Q1 		$1K Sell
438
-478
-52% -$2.55K ﹤0.01% 4011
2019
Q4 		$6K Buy
916
+216
+31% +$1.15K ﹤0.01% 4679
2019
Q3 		$3K Buy
700
+18
+3% +$61 ﹤0.01% 4623
2019
Q2 		$3K Buy
682
+681
+68,100% +$2.26K ﹤0.01% 4737
2019
Q1 		$0 Buy
+1
New +$7 ﹤0.01% 4863

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of Montreal's RVLP Position: Q2 2021 in Review

Bank of Montreal sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 374 shares — an estimated $1K sold.

Bank of Montreal first reported a position in RVLP in Q1 2019 and held it in 9 quarters. The position peaked at $9K in Q4 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Bank of Montreal reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 374 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $1K.
  • Bank of Montreal first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 9 quarters.
  • Bank of Montreal's RVL Pharmaceuticals plc Ordinary Shares position peaked at $9K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.